3401 Burgdorf, ch
+41 (34) 42441-43
Ypsomed launches new umbrella brand "mylifeTM Diabetescare"
More freedom, more fun. With mylife(TM)
The company behind mylife(TM) is Ypsomed, a Swiss-based global leader in the field of medical technology and self-medication, a company very well acquainted with the physical and emotional challenges that people with diabetes face in their everyday life. With its extremely discreet injection technologies and easy-to-operate pen needles and Pura blood glucose systems, mylife(TM) smoothes the way for simple and reliable self-medication. mylife(TM) helps customers achieve normality in their everyday life, giving them more freedom, fun, self-assurance and confidence in the life they want to lead. The fresh mylife(TM) green illustrates the values of mylife(TM) perfectly.
Ypsomed is the leading independent diabetes marketing specialist in Europe
Mr. Simon Michel, Head of Marketing & Sales at Ypsomed, explains, "With the new mylife(TM) umbrella brand we are aiming for synergies by placing Ypsomed's own products as well as those from third parties uniformly under a new global brand. With mylife(TM) , Ypsomed underlines its leading role as an independent distribution organization for diabetes products in Europe and at the same time raises its market presence. With the mylife(TM) umbrella brand, which is manufacturer-independent, Ypsomed is also an attractive partner for distributors."
Further expanding the range of products and services in the growth market of diabetes, with mylife(TM)
In the field of diabetes, Ypsomed finds itself in an interesting growth market, and in the future, under mylife(TM) , it will bring new, innovative products and services to the market. One example is the Clickfine® AutoProtect(TM) pen safety needle for doctors' practices, nursing homes and hospitals, which will be launched in mid-2010.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.